Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 15, Issue 7, 2009, Pages 689-695

  Huffman, David M ^a   McLean, George W ^a   Seagrove, Maighan A ^a  

^a UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; PRAMLINTIDE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MIDDLE AGED; PILOT STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AMYLOID; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; MIDDLE AGED; PILOT PROJECTS;

EID: 77449150237     PISSN: None     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP09044.ORR1     Document Type: Article

References (0)